Upcoming Presentations

UBC scientists participate in scientific and clinical meetings around the world. To learn more about a presentation, please contact the UBC scientist directly or call 301-654-9729.

  • ATS 2012

    May 18 - May 23 2012
    San Francisco, CA, USA
    conference.thoracic.org/2012/index.php


    SESSION PRESENTATION
    Mon., May 21, 12 noon - 1 p.m.
    Meet the Professor Seminar: Measurement Issues in COPD
    Nancy Kline Leidy, PhD, SVP Scientific Affairs, United BioSource Corporation 

    POSTER PRESENTATIONS
    Conceptualization Of Symptoms And Symptom Impacts Among Adults With Inadequately Controlled Moderate-Severe Asthma
    McLaurin KK, Pokrzywinski R, O'Quinn S, Xu X, Hareendran A

    COPD Patients’ Experience Of Early Morning Symptoms: Results From Qualitative Research
    Mocarski M, Houghton K, Palsgrove A, Hareendran A, Schaefer M, Carson R, Setyawan J, Make BJ

    Quantifying the Severity of Respiratory Symptoms of COPD: Performance Properties of the E-RS in 3 Randomized Controlled Trials
    Murray LT, Houle C, Stolar M, Hsieh R, Jones P, Monz BU, Ramachandran S, Goldman M, Sethi S, Leidy NK

    Reliability And Validity Of EXAcerbations of Chronic Pulmonary Disease Tool (EXACT) Scores In 3 Clinical Trials
    Houle C, Murray LT, Stolar M, Hsieh R, Jones P, Sethi S, Ramachandran S, Goldman M, Leidy NK on behalf of the EXACT-PRO Initiative

  • AUA Annual Meeting 2012

    May 19 - May 23 2012
    Atlanta, GA, USA
    www.aua2012.org/


    POSTER PRESENTATIONS
    The Association of Overactive Bladder with Physical Activity in the United States: Results from OAB-POLL
    Coyne KS, Sexton CC, Clemens JQ, Thompson CL, Chen C-I, Bavendam T, Dmochowski R

    The Relationship between BMI and Urinary Incontinence Subgroups: Results from EpiLUTS
    Khullar V, Sexton CC, Thompson CL, Milsom I, Bitoun CE, Coyne KS

  • ISPOR 17th Annual International Meeting

    Jun 2 - Jun 6 2012
    Washington, DC, USA
    www.ispor.org/default.asp


    SHORT COURSES

    Bayesian Analysis – Overview and Applications
    Sat., June 2, 8:00 a.m. - 5:00 p.m. 
    Faculty:  David J. Vanness, PhD, Asst. Prof., Univ. of Wisconsin, School of Medicine and Public Health and Visiting Scientist, Health Economics and Science Policy, United BioSource Corp.; Christopher S. Hollenbeak, PhD, Assoc. Prof., Surgery and Public Health Sciences, Penn State College of Medicine

    Discrete Event Simulation for Economic Analyses – Concepts 
    Sun., June 3, 8:00 a.m. - 12:00 p.m.
    Faculty:      J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill Univ. and SVP of Health Economics, United BioSource Corp.; Jorgen Moller, MSc Mech Eng, VP, Modeling, United BioSource Corp.; Denis Getsios, Senior Dir., Senior Research Scientist, United BioSource Corp.

    Bayesian Analysis – Advanced 
    Sun., June 3, 8:00 a.m. - 12:00 p.m.
    Faculty:      Keith R. Abrams, PhD, Prof. of Medical Statistics, Dept. of Health Sciences, Univ. of Leicester; David J. Vanness, PhD, Asst. Prof., University of Wisconsin School of Medicine and Public Health and Visiting Scientist, Health Economics and Science Policy, United BioSource Corp.; Christopher S. Hollenbeak, PhD, Assoc. Prof. Surgery and Public Health Sciences, Penn State College of Medicine

    Content Validity of PRO, ClinRO and ObsRO Assessments
    Sun., June 3, 1:00 p.m. - 5:00 p.m.
    Faculty:     Donald L. Patrick, PhD, MSPH, Prof. Univ. of Washington, Seattle Quality of Life; Mona L. Martin, RN, MPA, Exec. Dir. Health Research Associates; Chad Gwaltney, PhD, Sr. Scientist PRO Consulting and Asst. Prof. (Research), Brown Univ.; Nancy Kline Leidy, PhD, SVP Scientific Affairs, United BioSource Corp.

    Discrete Event Simulation for Economic Analyses – Applications 
    Sun., June 3, 1:00 p.m. - 5:00 p.m.
    Faculty:      J. Jaime Caro, MDCM, FRCPC, FACP, Adjunct Prof. of Medicine, Adjunct Prof. of Epidemiology and Biostatistics, McGill Univ. and SVP of Health Economics, United BioSource Corp.; Jorgen Moller, MSc Mech Eng, VP, Modeling, United BioSource Corp.; Denis Getsios, Senior Dir., Senior Research Scientist, United BioSource Corp.


    WORKSHOPS

    W2: Eliciting Patient-Centered Outcomes: Determining the Relative Strengths, Opportunities and Challenges of 5 Common Research Designs
    SESSION I     Mon., June 4, 4:45 p.m. - 5:45 p.m.
    Discussion Leaders:     Bryan R. Luce, PhD, MBA, SVP, Science Policy, United BioSource Corp.; Lori Frank, PhD, Research Scientist, Patient Centered Outcomes Research Institute; Karin S. Coyne, PhD, MPH, Senior Research Leader, Outcomes Research, United BioSource Corp.; Kathleen W. Wyrwich, PhD, Senior Research Leader, United BioSource Corp.

    W19: Comparative Effectiveness Research: Methods and Applications
    SESSION III     Wed., June 6, 8:30 a.m. - 9:30 a.m.
    Discussion Leaders:     Donald L. Patrick, PhD, MSPH, Dir., Seattle Quality of Life Group, Univ. of Washington; Bryan R. Luce, PhD, MBA, SVP, Science Policy, United BioSource Corp.; C. Daniel Mullins, PhD, Professor, Pharmaceutical Health Services Research Dept., Univ. of Maryland School of Pharmacy
     
    W22: Early Economic Evaluation of the Effectiveness of Pharmaceutical Development Candidates in Subpopulations: A Role for Clinical Trial Modeling and Simulation
    SESSION IV     Wed., June 6, 1:45 p.m. - 2:45 p.m.
    Discussion Leaders:     Ananth Kadambi, PhD, Dir., Modeling and Simulation Development and Research Scientist, Health Economics, United BioSource Corp.; Robert Leipold, PhD, Research Scientist, Health Economics, United BioSource Corp.; Thomas Paterson, MS, Chief Technology Officer, Entelos; Christy J. Chuang-Stein, PhD, VP, Statistical Research and Consulting Center, Pfizer


    PODIUM PRESENTATION

    MA1: Medication Adherence and Persistence of Prasugrel Initiators Post ACS-PCI
    SESSION II     Mon., June 4, 3:15 p.m. - 3:30 p.m.
    Simeone JC, Nordstrom B, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB


    POSTER PRESENTATIONS

    SESSION I - Mon., June 4, 8:30 a.m. - 2:00 p.m

    PHP46:     Design and Operational Challenges with Time and Motion (T&M) Studies Run Alongside Clinical Trials
    De Cock E, Payne K, Urspruch A

    PMS81: Factors Predicting Pain Medication Selection Among Patients with Osteoarthritis
    Wu N, Chen SY, Andrews JS, Boulanger L, Peng X

    PMS82: Factors Associated with Initiation of High-Dose Duloxetine Among Patients with Osteoarthritis
    Peng X, Wu N, Andrews JS, Chen SY, Boulanger L

    PMS86: Use of Common Data Model to Enable Meaningful Comparison of Disease Burden Among Disparate Databases
    Schneider G, Powell G, Reisinger S

    SESSION II - Mon., June 4, 4:30 - 8:30 p.m.

    PMD23: Healthcare Utilization and Costs in Patients Experiencing Bone Fracture Nonunion
    Wu N, Lee YC, Graham R, Segina DN, Wilcox T, Boulanger L

    PMD59: Assessment of Administrative Data for Evaluating the Shifting Acquisition of Clostridium Difficile Infection in England
    Jen MH

    PMD61: Evaluating the Usability of an ePRO Diary for Measuring COPD Symptoms at Night and Early Morning
    Eremenco S, Palsgrove A, Mocarski M, O'Donohoe P, Hareendran A

    PMH26: Modeling Economic Consequences of Cardiometabolic Changes with Lurasidone Versus Other Atypical Antipsychotics in Schizophrenia
    Bollu V, Guo S, Green J, Hernandez L, Rajagopalan K

    PMH50: Psychiatrists' Preferences for Attributes of Antipsychotic Medications to Treat Schizophrenia: A Conjoint Analysis
    Gelhorn H, Gries KS, Cho C, Thompson C, Fastenau J

    PSU21: Health Care Costs and Utilization Between Patients Receiving Total Knee Replacement Surgery With and Without Muscle Atrophy/Weakness
    Chen SY, Lee YC, Wu N, Zhao Y

    PSU27: Clinical and Economic Characteristics of Patients Receiving Total Hip Replacement Surgery With and Without Muscle Atrophy/Weakness
    Zhao Y, Chen SY, Lee YC, Wu N

    PSU41: Day of Week of Procedure and 30-Day In-Hospital Mortality for Elective Surgery
    Jen MH

    PSU8: Disease Burden and Medical Needs in Older Patients with Total Knee Arthroplasties and Muscle Atrophy or Weakness
    Green J, Hallett L, Zhao Y, Birt J, Foster T

    PSY2: Adverse Event Burden, Resource Use and Costs Associated with Immunosuppressant Therapy for the Treatment of Systemic Lupus Erythrematosis: A Systematic Literature Review
    Shaul A, Pokora T, Paramore C, Cragin LS, Weinstein A, Dennis GJ, Narayanan S, Oglesby AK

    PSY40: Are Neuropathic Pain (NP) Treatment Benefits Reflected in the Self Assessment of Treatment (SAT) Questionnaire?
    Wiklund I, Holmstrom S, Wyrwich K, Devine M, Stoker M

    PSY59: Variation in Health-Related Quality of Life Associated with Changes in Transfusion Status of Patients with Myelodysplastic Syndromes Across Six Months of Treatment with Azacitidine
    Pashos CL, Grinblatt DL, Sekeres MA, Komrokji RS, Narang M, Swern AS, Street TK, Sullivan KA, Harding G, Khan ZM

    PSY62: Predictors of Pain Medication Selection Among Patients Diagnosed with Chronic Lower Back Pain
    Wu N, Chen SY, Andrews JS, Boulanger L, Peng X

    PSY63: Factors Predicting the Initiating Dose of Duloxetine Among Patients with Chronic Lower Back Pain: A Retrospective Commercial Claims Analysis
    Andrews JS, Wu N, Peng X, Chen SY, Boulanger L

    SESSION III - Tues., June 5, 8:45 a.m. - 1:15 p.m.

    PCV7: Impact of Comorbidities on Risk of Cardiovascular Hospitalization Among Patients With and Without Atrial Fibrillation
    Panaccio M, Cummins G, Miao R, Davis P, Wentworth C, Lanes S, Reynolds M, Michels S, Koren A

    PCV118: Characteristics of Patients Treated with Thienopyridines Following ACS-PCI
    Nordstrom B, Simeone JC, Zhao Z, Molife C, McCollam PL, Ye X, Effron MB

    PGI8: Prevalence of Gastroprotective Agent Use Among Adults with Arthritis Taking Nsaids
    Coyne KS, Margolis MK, Cappelleri JC, Hsieh R, Essex MN, Park PW, Joshi AV

    PND14: Economic Burden of Refractory Epilepsy with Partial Onset Seizures - an Assessment of Direct Health Care Resource Use and Costs
    Chen SY, Wu N, Boulanger L, Sacco P

    PUK10: Cost Savings of Peritoneal Dialysis Versus Conventional In-Center Hemodialysis Under Medicare Bundled Payment System
    Liu FX, Inglese G, Leipold R, Patterson J, Abbott G, Wilson D

    SESSION IV - Tues., June 5, 3:45 - 7:45 p.m.

    PDB16: Treated to Glycemic Control Target Assessed by Fasting Plasma Glucose (FPG) and Glycated Hemoglobin (HBA1C) in Patients with Type II Diabetes
    Li Q, Bouchard JR, Wu N, Boulanger L

    PDB98: Treatment Patterns and Treatment Restrictions of Patients with Type II Diabetes Receiving Care From Home Healthcare Agencies, Skilled Nursing Facilities, and Veterans Affairs Settings in the US
    Ganz ML, Strand L, Kongso JH

    PIH3: Use of Mixed Treatment Comparison Methods in Estimating Efficacy of Treatments for Heavy Menstrual Bleeding
    Hoaglin D, Filonenko A, Wasiak R

    PRM4: Enhancing the Health Economic Value of Retrospective and Prospective Real-World Studies with Pharmacogenomic Testing: Opportunities and Challenges Associated with an Integrated Personalized Medicine Approach
    Payne KA, Frueh FW, Sohal J

    PRM5: Validity of Requiring a Minimum Duration of Post-Index Enrollment in Retrospective Database Studies
    Lanes SF

    PRM62: Visual Assessment of Fit of Equations to Predict Time-to-Event Outcomes
    Ishak KJ

    SESSION V - Wed., June 6, 8:30 a.m. - 2:45 p.m.

    PCN103: Variation in Health-Related Quality of Life by Age Among Patients with Chronic Lymphocytic Leukemia
    Pashos CL, Flowers CR, Weiss M, Lamanna N, Farber C, Kipps TJ, Lerner S, Kay N, Sharman J, Grinblatt dL, Flinn IW, Kozloff MF, Swern AS, Khan Z, Street TK, Sullivan KA, Harding G, Keating MJ

    PCN142: Association of Health-Related Quality of Life Among Patients with Multiple Myeloma with Insurance Coverage
    Pashos CL, Durie BG, Rifkin RM, Abonour R, Fonseca R, Gasparetto C, Mehta J, Narang M, Shah JJ, Terebelo HR, Thomas S, Toomey K, Swern AS, Harding G, Yu R, Sullivan KA, Street TK, Khan ZM

    PIN11: Costs of Adverse Events Among Patients with Human Immunodeficiency Virus Treated with Non-Nucleoside Reverse Transcriptase Inhibitors
    Simpson KN, Chen SY, Wu A, Boulanger L, Khachatryan A, Chambers R, Tawadrous M, Pashos CL, Haider S

    PIN50: Responsiveness of the MOS-HIV and EQ-5D in HIV-Infected Adults Receiving Antiretroviral Therapies
    Wu AW, Hanson KA, Harding G, Haider S, Tawadrous M, Khachatryan A, Pashos CL, Simpson KN

  • ISNM 2012 Annual Meeting

    Jun 9 - Jun 13 2012
    Miami Beach, FL, USA
    interactive.snm.org/index.cfm?PageID=10963


    POSTER PRESENTATION
    Sulfur Colloid Injection (SCI) for Lymph Node Localization (LNL): Systematic Literature Review and Meta-analysis
    Silverman M, Fahrbach K, Nalysnyk L

  • 22nd Meeting of the European Neurological Society

    Jun 9 - Jun 12 2012
    Prague, Czech Republic
    www.congrex.ch/ens2012


    ORAL PRESENTATION
    Global Epidemiology of Amyotrophic Lateral Sclerosis: a Systematic Review of the Published Literature
    Chio A, Logroscino G, Traynor B, Collins J, Simeone J, Nalysnyk L, White LA

  • 2012 ASHP (American Society of Health-System Pharmacists) Summer Meeting

    Jun 9 - Jun 13 2012
    Baltimore, MD, USA
    www.ashpfoundation.org/MainMenuCategories/AboutUs/SummerMeeting.aspx


    POSTER PRESENTATION
    Long-term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Non-valvular Atrial Fibrillation
    Siu K, Wu N, Wu S, Walker DR, Mercaldi CJ

  • The MDS 16th International Congress of Parkinson's Disease and Movement Disorders

    Jun 17 - Jun 21 2012
    Dublin, Ireland
    www.mdscongress2012.org/index.php


    POSTER PRESENTATION
    OnabotulinumtoxinA for Adult Spasticity: A Systematic Review of the Literature
    Papapetropoulos S, Nalysnyk L, Rotella P, Simeone J, Alter KE, Esquenazi A

  • DIA 2012 48th Annual Meeting

    Jun 24 - Jun 28 2012
    Philadelphia, PA, USA
    www.diahome.org/DIAHome/Home.aspx


    Mon., June 25, 1:30 - 3:30 p.m.

    SESSION SPEAKER
    A Writer's Perspective on Safety Documents Before the Marketing Application
    Michael D. Hoffman, MS, Senior Director, Medical Writing and Regulatory Operations, United BioSource Corporation

    Mon., June 25, 3:30 - 5:00 p.m.

    SESSION SPEAKERS
    PRO Consortia: A Success Story
    Nancy Kline Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation

    Epidemiologic Studies as Part of Risk Management Strategies for Marketed Products
    Catherine Sigler, DVM, MPH, Senior Epidemiologist, United BioSource Corporation

    Tues., June 26, 10:00 - 11:30 a.m.

    SESSION PANELIST
    Collaborative Research with Members of the Payer Community
    Felix Frueh, PhD, Personalized Medicine, United BioSource Corporation

    Tues., June 26, 12:00 - 1:30 p.m.

    SESSION PANELIST
    Challenges of Precision Medicine: Diagnostics, Reimbursement, Partnership Co-Development
    Felix Frueh, PhD, Personalized Medicine, United BioSource Corporation

    Wed., June 27, 10:00 - 11:30 a.m.

    SESSION CHAIR AND SPEAKER
    Natural History Studies for Rare Diseases and Orphan Conditions
    Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, United BioSource Corporation

    Wed., June 27, 1:30 - 3:00 p.m.

    SESSION CHAIR
    Data Sources for Monitoring Usage of Drug Products and How to Use these Sources to Support Safety and REMS Evaluations
    Juliane Mills, Project Manager, SERRM, United BioSource Corporation

  • 9th Annual Meeting HTAi Bilbao 2012

    Jun 25 - Jun 27 2012
    Bilbao, Spain
    www.htai2012.org/


    PANEL SESSION
    How to Optimally Assess the Relative Value of Disease Modifying Treatments in Multiple Sclerosis
    Panel Coordinator: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation

    ORAL PRESENTATION
    Innovation, Innovation Everywhere - What is Innovation?
    J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation

  • CBI's 2nd Annual Bio/Pharmaceutical Conference on New Product Forecasting

    Jun 26 - Jun 27 2012
    Philadelphia, PA, USA
    www.cbinet.com/conference/pc12138


    Wed., June 27, 1:30 p.m.

    SESSION SPEAKER 
    New Product Forecasting in the Era of Personalized Medicine
    Michael Epstein, Director and Practice Leader, Commercial Strategy Practice, United BioSource Corporation

  • AAIC 2012 Alzheimer's Association International Conference

    Jul 14 - Jul 19 2012
    Vancouver, British Columbia, Canada
    www.alz.org/aaic/


    POSTER PRESENTATIONS
    vMRI and Hippocampal Volume in Patients with Suspected Predementia Alzheimer’s Disease
    Budd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman RM, Burns LC, L'Italien G 

    vMRI and Whole-brain Volume in Patients with Mild-to-Moderate Alzheimer’s Disease
    Budd D, Nalysnyk L, Fahrbach K, Bhagwagar Z, Berman RM, Burns LC, L'Italien G

  • AIDS 2012

    Jul 22 - Jul 27 2012
    Washington, DC, USA
    www.aids2012.org/


    POSTER PRESENTATION
    Patient Reported Outcome Instruments Used in Clinical Trials of HIV-infected Adults on NNRTI-based Therapy: A 5-year Review
    Simpson KN, Hanson KA, Harding G, Haider S, Tawadrous M, Khachatryan A, Pashos CL, Wu AW

  • ISPOR 5th Asia-Pacific Conference

    Sep 2 - Sep 4 2012
    Taipei, Taiwan
    www.ispor.org/Events/Main.aspx?eventId=37


    WORKSHOP PRESENTATION
    W1: Using Individual Simulation to Forecast Disease Epidemiology and Burden of Illness
    SESSION I     Mon., 3 September, 11:00 - 12:00
    Discussion Leaders: Feng Pan, PhD, Senior Research Associate, Thitima Kongnakorn, PhD, Senior Research Associate, United BioSource Corporation; John Cai, PhD, Professor, China Europe International Business School, Center for Health Policy and Management

    POSTER PRESENTATION
    Burden of Multiple Sclerosis (MS) in China
    Hu S, Pan F, Goh JW

  • Late Phase & Real World Evidence Leaders' Summit 2012

    Oct 8 - Oct 10 2012
    Vienna, Austria
    www.nextlevelpharma.com/


    SESSION PRESENTATIONS
    Getting the Right Evidence From Your Late Stage Activities: The Importance of Planning Ahead
    Teresa (Terry) K. Wilcox, RPh, PhD, Senior Research Leader, Evidence Generation Strategy, United BioSource Corporation

    The Role of the Pragmatic Trial in Late Phase Research
    Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource Corporation
    Alan J. Nelson, Project Director, United BioSource Corporation

  • 11th Annual Partnerships in Clinical Trials Europe 2012

    Nov 6 - Nov 9 2012
    Hamburg, Germany
    www.informaglobalevents.com/event/PCT2012


    SESSION PRESENTATION
    Case Study: How Global, Multi-service Line Strategic Alliances between Biopharma and Service Providers Can Influence the Success of Product Development
    Jonathan Morris, MD, Senior Vice President and Chief Scientific Officer, United BioSource Corporation
    Tehseen Salimi, MD, MHA, Vice President Global & Value Development, Sanofi